Webinars

10.13.20

Navigating the Surge in Telehealth Transactions

The first quarter of 2020 saw venture capital funding for telemedicine companies surging to $788 million—a jump of 258% over last year.




10.08.20

Navigating FDA Regulation During COVID-19

Using the Emergency Use Authorization (EUA) process, the Food and Drug Administration (FDA) has made enormous strides since the start of the COVID-19 crisis to facilitate the availability of diagnostic tests, ventilators, personal protective equipment and other critical medical technologies.




09.30.20

Implementing the ONC Information Blocking Rule

In March, the federal Office of the National Coordinator for Health Information Technology (ONC) issued a final rule implementing the information blocking prohibition in the 21st Century Cures Act.




09.01.20

The TCPA and COVID-19: What Healthcare Organizations Need to Know

On March 20, 2020, the Federal Communications Commission (FCC) issued a Declaratory Ruling that exempted certain calls and texts related to COVID-19 from Telephone Consumer Protection Act (TCPA) requirements.




08.27.20

Drug Pricing Proposals, Policies, Pushback and Politics: What’s New, What’s Needed and What’s Next

On July 24, President Trump signed four executive orders (EOs) designed to lower drug prices, adding new fuel to the already raging debate around prescription drug costs.




05.12.20

COVID-19: Remapping the Healthcare Privacy Landscape

Privacy is among the many areas of our lives that COVID-19 is radically changing.




03.26.20

Federal and State Policy Levers to Maintain Access to MOUD During the COVID-19 Pandemic

The COVID-19 pandemic has adversely impacted vulnerable populations, particularly individuals with opioid use disorder (OUD). Individuals with OUD are more likely to experience homelessness or incarceration and may be at increased risk of exposure to COVID-19.